Search

Showing total 982 results

Search Constraints

Start Over You searched for: Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals Topic blood proteins Remove constraint Topic: blood proteins Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
982 results

Search Results

1. Protein precipitation coupled to paper spray with a tube for one-step analysis of blood.

2. Selection of a filter paper with optimum properties for the collection of gingival crevicular fluid.

3. Immunoglobulin G and low molecular weight proteins in human cerebrospinal fluid. Chemical and immunological characterisation with special reference to multiple sclerosis.

4. Evaluation of 92 cardiovascular proteins in dried blood spots collected under field‐conditions: Off‐the‐shelf affinity‐based multiplexed assays work well, allowing for simplified sample collection.

5. Immunoadsorbent Assay Application for Studies of Protein Mixtures and Usage of Paper Carriers.

6. ORIGINAL PAPER The impact of different intensities of regular donor plasmapheresis on humoral and cellular immunity, red cell and iron metabolism, and cardiovascular risk markers.

7. research paper Thrombotic disease in systemic lupus erythematosus is associated with a maintained systemic platelet activation.

8. ORIGINAL PAPER ‘Last-ditch’ use of recombinant factor VIIa in patients with massive haemorrhage is ineffective.

9. Profiling of intact blood proteins by matrix‐assisted laser desorption/ionization mass spectrometry without the need for freezing – Dried serum spots as future clinical tools for patient screening.

10. Reducing blood product wastage through the inter‐hospital redistribution of near‐outdate inventory.

11. Targeted deep learning: Framework, methods, and applications.

12. Preclinical development and characterization of a human plasma‐derived high‐purity factor X concentrate for therapeutic use.

13. Fabrication and characterization of glutathione‐responsive nanoparticles from the disulfide bond‐bridged block copolymer.

14. Azurocidin in gingival crevicular fluid as a potential biomarker of chronic periodontitis.

15. Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development.

16. Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory.

17. SCARF2 is a target for chronic obstructive pulmonary disease: Evidence from multi‐omics research and cohort validation.

18. Proteomic analysis of serum in a population‐based cohort did not reveal a biomarker for Modic changes.

19. Simultaneous assessment of complement components C3, C4, and B and their cleavage products in human gingival fluid: I. Reliability of the method.

20. Protein characterization using electrophoresis and immunofixation; a case‐based review of dogs and cats.

21. Pig‐a gene mutation database.

22. Different PES nanofibrous membrane parameters effect on the efficacy of immunoassay performance.

23. Mechanisms of plasma non-transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients.

24. Optimized AF4 combined with density cushion ultracentrifugation enables profiling of high‐purity human blood extracellular vesicles.

25. Understanding the Influence of Serum Proteins Adsorption on the Mechano‐Bactericidal Efficacy and Immunomodulation of Nanostructured Titanium.

26. Blood‐based inflammatory protein biomarker panel for the prediction of relapse and severity in patients with neuromyelitis optica spectrum disorder: A prospective cohort study.

27. Well‐controlled mucosal exudation of plasma proteins in airways with intact and regenerating epithelium.

28. Re‐discover the value of protein binding assessments in hepatic and renal impairment studies and its contributions in drug labels and dose decisions.

29. CONCEPTS OF SEROMA FORMATION AND PREVENTION IN BREAST CANCER SURGERY.

30. The benefit of dupilumab as a postoperative short‐term adjuvant therapy for chronic rhinosinusitis with nasal polyps: A preliminary study.

31. The mechanism of iron uptake by transferrins: the X-ray structures of the 18 kDa NII domain fragment of duck ovotransferrin and its nitrilotriacetate complex.

32. MAD phasing with krypton.

33. α-Defensins and bacterial/permeability-increasing protein as new markers of childhood obesity.

34. Harnessing the Potential of Blood Proteins as Functional Ingredients: A Review of the State of the Art in Blood Processing.

35. Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors.

36. Characterization of the human transferrin and lactoferrin receptors in Haemophilus influenzae.

37. Global Analysis of Antibody Repertoires. 1. An Immunoblot Method for the Quantitative Screening of a Large Number of Reactivities.

38. Complete primary structure of bovine plasma fibronectin.

39. No evidence of association between either Modic change or disc degeneration and five circulating inflammatory proteins.

40. The Arabidopsis R‐SNARE VAMP714 is essential for polarisation of PIN proteins and auxin responses.

41. Bovine Serum Albumin Catalysed Hydrogen and Deuterium Evolution at Mercury Electrodes.

42. Haptoglobin therapy has differential effects depending on severity of canine septic shock and cell-free hemoglobin level.

43. Altered microheterogeneity at several N‐glycosylation sites in OPSCC in constant protein expression conditions.

44. A comparison of the exposure system of glycidol‐related chemicals on the formation of glycidol‐hemoglobin adducts.

45. Serum C‐reactive protein greater than 75 mg/dL as an early available laboratory predictor of severe COVID‐19: A systematic review.

46. Plasma tumour necrosis factor‐alpha‐related proteins in prognosis of heart failure with pulmonary hypertension.

47. Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans.

48. Late‐life plasma proteins associated with prevalent and incident frailty: A proteomic analysis.

49. Chemical and Biological Mechanisms of Pathogen Reduction Technologies.

50. Development of a highly sensitive liquid chromatography/tandem mass spectrometry method to quantify total and free levels of a target protein, interferon-gamma-inducible protein-10, at picomolar levels in human serum.